The Centre for Bioinformatics, Biomarker Discovery and Information-Based Medicine is committed to shortening the process of obtaining novel discoveries to achie

Priority Research Centre for
BIOINFORMATICS, BIOMARKER DISCOVERY AND INFORMATION-BASED MEDICINE

News

12 results found.

MS researchers to explore environmental triggers

MS researchers to explore environmental triggers

Thursday, 5 March 2015

Hunter Medical Research Institute researcher Associate Professor Jeannette Lechner-Scott is investigating the environmental risk factors surrounding multiple sclerosis after receiving a $220,000 project grant from MS Research Australia.

Schizophrenia research first

Schizophrenia research first

Wednesday, 4 March 2015

Associate Professor Murray Cairns has received an $800,000 2014/15 NSW Genomics Collaborative Grant to explore better treatments for schizophrenia.

Breast cancer gene breakthrough

Breast cancer gene breakthrough

Tuesday, 24 February 2015

Hunter researchers have identified a significant new risk factor for triple-negative breast cancer (TNBC), impacting women who would currently fall outside genetic testing benchmarks for the disease.

Pablo Moscato: From bioinformatics to Shakespeare

Pablo Moscato: From bioinformatics to Shakespeare

Monday, 23 February 2015

Why does an eminent computer scientist team up with a Renaissance literature expert? To design a study using information theory and computer science methods and determine the authorship of plays and poems where that authorship is unknown or disputed, including some of the works of William Shakespeare.

Unlocking the power of personalised medicine

Unlocking the power of personalised medicine

Thursday, 18 September 2014

The University of Newcastle's (UON) Professor Pablo Moscato is leading the revolution of how some of medicine's greatest challenges, including Alzheimer's Disease and cancer, are approached.

New sequencer turbo-charges cancer risk diagnosis

New sequencer turbo-charges cancer risk diagnosis

Wednesday, 9 April 2014

A HMRI genetics laboratory at Newcastle's John Hunter Hospital has become the first in Australia, and one of the few in the world, to receive accreditation for a new diagnostic system that revolutionises 'NextGen' DNA sequencing for breast and ovarian cancer.

Shakespeare and cancer diagnoses: how bard can it be?

Shakespeare and cancer diagnoses: how bard can it be?

Monday, 22 July 2013

By Pablo Moscato, University of Newcastle; David Budden, University of Melbourne; Hugh Craig, University of Newcastle, and John W. Marsden, University of Newcastle

Shakespeare's plays and cancer: two seemingly unrelated topics with an underlying common thread.

Molecule may hold key to melanoma progression

Molecule may hold key to melanoma progression

Wednesday, 27 February 2013

The search for new pathways to treat melanoma has unearthed a molecular target that may play an important activation role in tumour growth, according to University of Newcastle researchers.